中国临床实用医学
中國臨床實用醫學
중국림상실용의학
CHINA CLINICAL PRACTICAL MEDICINE
2010年
10期
108-110
,共3页
胰岛素泵%糖尿病%动态血糖监测系统%低血糖
胰島素泵%糖尿病%動態血糖鑑測繫統%低血糖
이도소빙%당뇨병%동태혈당감측계통%저혈당
Insulin Pump%diabetes%Continuous Glucose Monitoring System%Hypoglycemia
目的 在胰岛素泵(CSII)皮下持续注射胰岛素的基础上,运用动态血糖监测系统(CGMS)监测血糖,研究联合方案对糖尿患者的治疗效果.方法 将48例糖尿病患者随机分为2组:对照组24例和治疗组24例.对照组单纯用胰岛素泵治疗,同时用血糖仪监测指血糖.治疗组用胰岛素泵联合动态血糖监测系统治疗(双C治疗),比较两组的相应血糖控制指标.结果 治疗组的低血糖发生率显著低于对照组(P＜0.05),治疗组血糖控制的一般情况要优于对照组,如血糖控制时间(4.3±1.7d v.s.6.4±2.3 d,P＜0.05),症状缓解时间(4.5±1.8 d v.s.6.6±2.5 d,P＜0.05),平均住院时间(7.1±2.5 d v.s 10.3±3.3 d,P＜0.01);两组血糖控制的一般情况表明实验组的血糖控制比对照组平稳.结论 胰岛素泵联合动态血糖监测系统治疗糖尿病效果要优于单纯使用胰岛素泵,能更好的控制血糖,可以在临床上推广.
目的 在胰島素泵(CSII)皮下持續註射胰島素的基礎上,運用動態血糖鑑測繫統(CGMS)鑑測血糖,研究聯閤方案對糖尿患者的治療效果.方法 將48例糖尿病患者隨機分為2組:對照組24例和治療組24例.對照組單純用胰島素泵治療,同時用血糖儀鑑測指血糖.治療組用胰島素泵聯閤動態血糖鑑測繫統治療(雙C治療),比較兩組的相應血糖控製指標.結果 治療組的低血糖髮生率顯著低于對照組(P＜0.05),治療組血糖控製的一般情況要優于對照組,如血糖控製時間(4.3±1.7d v.s.6.4±2.3 d,P＜0.05),癥狀緩解時間(4.5±1.8 d v.s.6.6±2.5 d,P＜0.05),平均住院時間(7.1±2.5 d v.s 10.3±3.3 d,P＜0.01);兩組血糖控製的一般情況錶明實驗組的血糖控製比對照組平穩.結論 胰島素泵聯閤動態血糖鑑測繫統治療糖尿病效果要優于單純使用胰島素泵,能更好的控製血糖,可以在臨床上推廣.
목적 재이도소빙(CSII)피하지속주사이도소적기출상,운용동태혈당감측계통(CGMS)감측혈당,연구연합방안대당뇨환자적치료효과.방법 장48례당뇨병환자수궤분위2조:대조조24례화치료조24례.대조조단순용이도소빙치료,동시용혈당의감측지혈당.치료조용이도소빙연합동태혈당감측계통치료(쌍C치료),비교량조적상응혈당공제지표.결과 치료조적저혈당발생솔현저저우대조조(P＜0.05),치료조혈당공제적일반정황요우우대조조,여혈당공제시간(4.3±1.7d v.s.6.4±2.3 d,P＜0.05),증상완해시간(4.5±1.8 d v.s.6.6±2.5 d,P＜0.05),평균주원시간(7.1±2.5 d v.s 10.3±3.3 d,P＜0.01);량조혈당공제적일반정황표명실험조적혈당공제비대조조평은.결론 이도소빙연합동태혈당감측계통치료당뇨병효과요우우단순사용이도소빙,능경호적공제혈당,가이재림상상추엄.
Objective To evaluate the effects of combined application of continuous glucose monitoring system(CGMS) and continuous subcutaneous insulin infusion(CSII)in patients with diabetes.Methods 48 cases of patients with diabetes were divided into two groups randomly-the control group(24 cases) and the treatment group(24cases).CGMS plus GSII were employed in the treatment group,while the control group only used the GSII method with the glucometer to monitor blood sugar.Then the level of the blood sugar were compared in both groups.Results The incidences of the low blood sugar of treatment group were significantly lower than the control group(P＜0.05);the general situation of the blood control in treatment group were also significantly better than the control group,such as blood sugar control time(4.3±1.7 d v.s.6.4±2.3 d,P＜0.05),symptom relief time(4.5±1.8 d v.s.6.6 ± 2.5 d,P＜0.05),average time in hospital(7.1±2.5 d v.s 10.3 ± 3.3 d,P ＜0.01) ;The situation of the blood glucose control for two groups suggested that the treatment group was more stable than the control group.Conclusion The effects of the technology combined insulin pump with CGMS is better than the CSII,which can better facilitated system treats.diabetes effect to surpass the pure use insulin pump,it can better control blood sugar,It should be possible to promote on clinical.
